Schedule 13G ownership disclosure

IONIS PHARMACEUTICALS INC

Common Stock · CUSIP: 462222100

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Wellington Management Group LLP

    Shares: 6,879,873.00 · Class: 4.3%

  • Wellington Group Holdings LLP

    Shares: 6,879,873.00 · Class: 4.3%

  • Wellington Investment Advisors Holdings LLP

    Shares: 6,879,873.00 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-25-000331
Form type
SCHEDULE 13G/A
Filer
IONIS PHARMACEUTICALS INC
CIK
CIK 874015
Filed
Aug 12, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub